CD8A and lung carcinoma: Despite limited direct evidence in lung cancer, Trp metabolites are generally increased in the lower airways of ICI responders [51,92], suggesting that a similar “microbiota–Trp metabolite–AhR–CD8+ T-cell” activation axis may exist in lung tumors.